Idioma:

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Rincon, Natalie L ; McDowell, Kelsey Rae ; Weatherspoon, Darien ; Ritchwood, Tiarney D ; Rocke, Daniel J ; Adjei Boakye, Eric ; Osazuwa-Peters, Nosayaba

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2313249-2313249 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por

Enviar para

Título:
Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years
Autor: Rincon, Natalie L ; McDowell, Kelsey Rae ; Weatherspoon, Darien ; Ritchwood, Tiarney D ; Rocke, Daniel J ; Adjei Boakye, Eric ; Osazuwa-Peters, Nosayaba
Assuntos: Adult ; adults aged 27–45 years ; Cross-Sectional Studies ; expanded HPV vaccine eligibility ; Female ; Healthcare Disparities ; HPV ; HPV vaccine uptake ; Human papillomavirus (HPV) ; Human Papillomavirus Viruses ; Humans ; Male ; National Health Interview Survey (NHIS) ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines ; racial disparities ; Racial Groups ; United States ; Vaccination
É parte de: Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2313249-2313249
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work and share first authorship.
Descrição: In 2018, the Food and Drug Administration expanded the age of eligibility for the human papillomavirus (HPV) vaccine to 27 to 45 years. However, it is unclear if there are racial/ethnic disparities in HPV vaccine uptake for this age-group following this expanded recommendation. We aimed to identify any disparities in HPV vaccine in 27 to 45 year-olds based on sociodemographic factors. We analyzed nationally representative, cross-sectional data from the 2019 National Health Interview Survey ( 9440). Logistic regression models estimated the odds of vaccine uptake (receipt of ≥1 vaccine dose) based on sociodemographic factors. Participants were mostly Non-Hispanic Whites (60.7%) and females (50.9%). In adjusted models, females had over three times greater odds of vaccine uptake compared to males (aOR = 3.58; 95% CI 3.03, 4.23). Also, compared to Non-Hispanic Whites, Non-Hispanic Blacks were 36% more likely (aOR = 1.36; 95% CI 1.09, 1.70), and Hispanics were 27% less likely (aOR = 0.73; 95% CI 0.58, 0.92) to receive the vaccine. Additionally, individuals without a usual place of care had lower odds of vaccine uptake (aOR = 0.72; 95% CI 0.57, 0.93), as were those with lower educational levels (aOR = 0.62; 95% CI 0.50, 0.78; aOR = 0.83; 95% CI 0.70, 0.98). There are disparities in HPV vaccine uptake among 27 to 45 year-olds, and adult Hispanics have lower odds of receiving the vaccine. Given the vaccine's importance in cancer prevention, it is critical that these disparities are addressed and mitigated.
Editor: United States: Taylor & Francis
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Rincon, Natalie L ; McDowell, Kelsey Rae ; Weatherspoon, Darien ; Ritchwood, Tiarney D ; Rocke, Daniel J ; Adjei Boakye, Eric ; Osazuwa-Peters, Nosayaba

United States: Taylor & Francis

Buscando em bases de dados remotas. Favor aguardar.